Back to News
Market Impact: 0.25

Claude Opus 4.7 has turned into an overzealous query cop, devs complain

HAS
Artificial IntelligenceCybersecurity & Data PrivacyTechnology & InnovationProduct LaunchesLegal & Litigation
Claude Opus 4.7 has turned into an overzealous query cop, devs complain

Anthropic's Claude Opus 4.7 is facing a surge in false-positive AUP refusals, with developers filing more than 30 complaints in April alone after only 2-7 per month in prior months. Users report the model is blocking benign cybersecurity, software development, and science tasks, including approved cyber-use cases that are not propagating properly through the API. The issue is creating customer frustration and could weigh on adoption, but it is unlikely to move markets broadly.

Analysis

This looks less like a one-off product bug and more like a monetization and trust problem that can compound quickly. When a model becomes “too safe” for paid workflows, the damage shows up first in usage intensity: developers route fewer prompts, shorten sessions, and stop sending ambiguous edge cases, which lowers API consumption even before churn appears in headline retention. That is especially dangerous for a premium coding/workflow SKU because the most valuable users are also the most likely to hit false positives in security, research, and data-heavy tasks. The second-order winner is not necessarily a direct rival model, but any workflow layer that can mediate policy friction: local agents, enterprise-hosted models, and open-source coding stacks become more attractive when the default model starts rejecting benign inputs. This can also accelerate multi-model orchestration inside enterprises, where procurement teams keep a “safe” model for general use but shift sensitive dev and research work elsewhere. Over 3-6 months, that fragmentation would pressure pricing power across premium AI copilots, not just this vendor. The reputational risk is asymmetric because the most vocal complaints come from high-signal customers: cybersecurity educators, researchers, and heavy technical users who influence broader adoption decisions. If the false positive rate persists for even another quarter, the market will start to price in lower net revenue retention and higher support costs, while also questioning whether the company’s “frontier safety” pitch is truly compatible with enterprise utility. The reversal catalyst is straightforward but operationally hard: measurable classifier loosening, explicit carve-outs for trusted workloads, and evidence that exemptions propagate correctly through API/product surfaces. The contrarian read is that a spike in refusals can be partly a growth artifact, and the company may be deliberately stress-testing guardrails before a broader model rollout. If management can show that rejection rates normalize after policy tuning, the current selloff in sentiment should fade quickly. But until there is proof, the burden of proof sits with the vendor, because trust losses in dev tooling tend to persist longer than the initial bug cycle.